Psychiatry Investig.  2022 Mar;19(3):213-219. 10.30773/pi.2021.0309.

A 24-Month Effects of Methylphenidate Use on Growth in Children and Adolescents With Attention Deficit Hyperactivity Disorder

• Lee Y
• Kong N
• Koo S
• Bai DS
• Kim Hj
• Jeong H
• Seo WS

• KMID: 2527417
• DOI: http://doi.org/10.30773/pi.2021.0309

Abstract

Objective
The primary objective of this study was to investigate the effect of methylphenidate (MPH) on height, weight, and body mass index (BMI) in drug-naive children and adolescents with attention deficit hyperactivity disorder (ADHD) over 24 months. The secondary objective was to investigate whether the age of MPH initiation and sex act as risk factors for growth retardation.
Methods
A total of 82 patients with ADHD were included. Weight, height, and BMI were measured at baseline and every 6 months up to 24 months. Weight, height, and BMI data were converted to z-scores and analyzed using two-way repeated-measures ANOVA and multiple linear regression.
Results
The z-score of height, weight and BMI decreased from the baseline values. The z-scores of height were at baseline 0.002; 6 months -0.100; 12 months -0.159; 18 months -0.159; 24 months -0.186. The z-scores of weight were at baseline 0.104; 6 months -0.155; 12 months -0.256; 18 months -0.278; 24 months -0.301. Here were no age and sex differences of height, weight, and BMI.
Conclusion
The use of MPH was associated with attenuation of weight and height gain rates in children and adolescents with ADHD.

Keyword

Child and adolescence psychiatry; Neurodevelopmental disorder; Pharmacology; Biological psychiatry